Researchers are increasingly leveraging the unique capabilities of the R4-6A2 reagent – an effective tool for inhibiting mouse IFNγ. This technique allows for a enhanced examination of immune cell activity, particularly in models of inflammation and autoimmunity, where IFNγ frequently plays a centra